<DOC>
	<DOCNO>NCT01916486</DOCNO>
	<brief_summary>The investigator conduct proof-of-concept randomized control trial study provide preliminary evidence efficacy exercise training complex mental social activity program improve cognitive function old adult chronic stroke , compare stretch relaxation program .</brief_summary>
	<brief_title>Vitality : Promoting Cognitive Function Older Adults With Chronic Stroke</brief_title>
	<detailed_description>A total 119 adult diagnose chronic stroke randomize either 6-month twice-weekly exercise program , complex mental social activity program , stretch relaxation program . After 6 month intervention , follow additional 6 month . There three measurement session : baseline , 6 month ( end intervention period ) ; 12 month .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>The study specifically recruit individual ischemic hemorrhagic stroke probable mild cognitive impairment . In addition , individual must meet follow inclusion criterion : 1 . Aged 55 year ; 2 . Have history single stroke least one year prior study enrolment ; 3 . MiniMental State Examination ( MMSE ) ( 5 ) score â‰¥ 20 screening , include perfect score 3step command ensure intact comprehension ability follow instruction ; 4 . Have subjective cognitive complaint ; 5 . Communitydwelling ; 6 . Lives Metro Vancouver ; 7 . Able comply schedule visit , treatment plan , trial procedure ; 8 . Must able read , write , speak English psychometric test provide acceptable visual auditory acuity ; 9 . Stable fix dose cognitive medication ( e.g. , donepezil , galantamine , rivastigmine , memantine , etc . ) expect change 12month study period , , medication , expect start 12month study period ; 10 . Able walk minimum six metre rest interval without assistive device ; 11 . Have activity tolerance 60 minute rest interval ; 12 . Not currently participate regular therapy progressive exercise ; 13 . Provide personally sign date informed consent document indicate individual ( legally acceptable representative ) inform pertinent aspect trial . In addition , assent form provide baseline regular interval . 1 . Diagnosed dementia type ; 2 . Diagnosed another type neurodegenerative neurological condition ( ie . Parkinson 's disease ) affect cognitive function mobility ; 3 . At high risk cardiac complication exercise and/or unable selfregulate activity understand recommend activity level ( i.e. , Class C American Heart Risk Stratification Criteria ) ; 4 . Have clinically significant peripheral neuropathy severe musculoskeletal joint disease impairs mobility , determine his/her family physician ; 5 . Taking medication may negatively affect cognitive function , anticholinergic , include agent pronounce anticholinergic property ( e.g. , amitriptyline ) , major tranquilizer ( typical atypical antipsychotic ) , anticonvulsant ( e.g. , gabapentin , valproic acid , etc . ) ; 6 . Have aphasia judge inability communicate phone .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>